Axsome Therapeutics Inc (NASDAQ: AXSM) kicked off on Monday, up 4.20% from the previous trading day, before settling in for the closing price of $139.69. Over the past 52 weeks, AXSM has traded in a range of $75.56-$144.15.
During the last 5-year period, the sales drop of Healthcare Sector giant was -24.44%. While this was happening, its average annual earnings per share was recorded 36.52%. With a float of $41.79 million, this company’s outstanding shares have now reached $50.31 million.
Axsome Therapeutics Inc (AXSM) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Axsome Therapeutics Inc is 17.11%, while institutional ownership is 74.00%. The most recent insider transaction that took place on Nov 05 ’25, was worth 2,954,650. Before that another transaction happened on Nov 03 ’25, when Company’s Chief Executive Officer sold 91,705 for $132.34, making the entire transaction worth $12,136,240. This insider now owns 7,229 shares in total.
Axsome Therapeutics Inc (AXSM) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.54 earnings per share (EPS), lower than consensus estimate (set at -1.04) by -0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Take a look at Axsome Therapeutics Inc’s (AXSM) current performance indicators. Last quarter, stock had a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.67, a number that is poised to hit -0.56 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Looking closely at Axsome Therapeutics Inc (NASDAQ: AXSM), its last 5-days average volume was 0.6 million, which is a drop from its year-to-date volume of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 74.90%.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 97.79%, which indicates a significant increase from 95.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 5.89 in the past 14 days, which was higher than the 4.07 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $126.62, while its 200-day Moving Average is $115.76. However, in the short run, Axsome Therapeutics Inc’s stock first resistance to watch stands at $148.53. Second resistance stands at $151.49. The third major resistance level sits at $156.31. If the price goes on to break the first support level at $140.75, it is likely to go to the next support level at $135.93. Should the price break the second support level, the third support level stands at $132.97.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
The company with the Market Capitalisation of 7.34 billion has total of 50,413K Shares Outstanding. Its annual sales at the moment are 385,690 K in contrast with the sum of -287,220 K annual income. Company’s last quarter sales were recorded 170,990 K and last quarter income was -47,230 K.
